Published in
SSRN Electronic Journal, 2021
DOI: 10.2139/ssrn.3945001
Frontiers Media, Frontiers in Medicine, (8), 2021
Links
Tools
Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report
Journal article published in 2021 by
Serge Goldman,
Dominique Bron,
Thomas Tousseyn 
,
Irina Vierasu,
Laurent Dewispelaere,
Pierre Heimann,
Elie Cogan,
Michel Goldman
,
Irina Vierasu,
Laurent Dewispelaere,
Pierre Heimann,
Elie Cogan,
Michel Goldman
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Since nucleoside-modified mRNA vaccines strongly activate T follicular helper cells, it is important to explore the possible impact of approved SARS-CoV-2 mRNA vaccines on neoplasms affecting this cell type. Herein, we report and discuss unexpected rapid progression of lymphomatous lesions after administration of a BNT162b2 mRNA vaccine booster in a man recently diagnosed with AITL.